Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US

CurifyLabs, a Finnish startup, raised $14 million to expand its 3D-printed personalized medicine technology in the US, where it already operates in pharmacies across 21 states. Their PharmaPrinter Aurum automates drug compounding, producing tailored doses faster and meeting FDA standards. The funding will support US growth, supply chain, and research efforts.